The antibacterial drugs market is encountering numerous challenges, ranging from regulatory barriers, patent expirations, to low returns on investment. Patent expirations of blockbuster drugs are further offering ground to regional and local players to introduce generic drugs, which is hard-hitting the sales of branded drugs.
However, rise in public-private funding is projected to underpin the development of novel drugs, thereby strengthening the pipeline for new therapeutics in the antibacterial drugs market. On the backdrop of these influences, a recently published report by Fact.MR portends that, the antibacterial drugs market will expand at a sluggish CAGR of 1.5% during the forecast period (2020-2025).
For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=4340
Key Highlights of Antibacterial Drugs Market Study
- Macrolides are fast-replacing quinolones, on the back of their high efficiency; however, the growing use of β-lactam in parallel to a large number of pipeline drugs in the phase-3 trial stage is expected to retain the lead of this drug class during the forecast period.
- Convenience remains a key determiner when it comes to preferred route of administration. Patients’ proclivity for enteral drugs is projected to increase, on account of oral therapy and relatively safe use than the parenteral route of administration.
- Currently, e-pharmacies witness challenges, such as non-complacency of e-retailers with government regulations, concerns regarding credibility of prescription, drug counterfeiting, and delay in shipping. However, in the future, this distribution channel will remain integral in driving sales from overseas markets.
- Wide availability of over-the-counter (OTC) drugs and generic drugs could limit the penetration of drugs in the Asia Pacific antibacterial drugs market. However, patent expiration of drugs in North America and Europe will also lead to a shift from branded drugs to generic ones, which could prevent the antibacterial drugs market from realizing its true revenue potential.
For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4340
Antibacterial Drugs Market – Assessment of Key Segments
With an aim to offer granular level insights into the antibacterial drugs market, authors of the report have segmented the landscape on the basis of drug class, route of administration, distribution channel, and region. This global research report also analyses the incremental opportunity available in the antibacterial drugs market during the forecast period. Key segments of the antibacterial drugs market include:
| Drug Class |
|
| Route of Administration |
|
| Distribution Channel |
|
| Region |
|
Collaborations of players in the antibacterial drugs market with academia, biotech companies, regulatory authorities, and pharmaceutical companies are also seen as a strategic move to gain the reciprocal advantage of technology and expertise.
For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4340
Why Choose Fact.MR?
- 24/7 Service Offering
- Digital Business Strategy Solutions
- Precise Supply Chain Augmentation Analysis
- Syndicated and Customized Reports for Clients
- Up-To-Date Insights on Industry Trends
Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2019/03/21/1758497/0/en/Dental-Lasers-Market-to-Surge-1-5x-through-2022-North-America-Remains-the-Largest-Market-Fact-MR.html
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
